AQST DEADLINE: ROSEN, A TOP-RANK FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - AQST

robot
Abstract generation in progress

Rosen Law Firm is encouraging investors of Aquestive Therapeutics, Inc. (NASDAQ: AQST) who purchased securities between June 16, 2025, and January 8, 2026, to secure legal counsel before the May 4, 2026, lead plaintiff deadline for a securities class action lawsuit. The lawsuit alleges that Aquestive made false and/or misleading statements regarding its New Drug Application for Anaphylm, specifically minimizing issues related to the human factors involved in the use of its sublingual film. Investors who suffered damages are urged to contact Rosen Law Firm for information on joining the class action.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin